iPharma, together with our partners, launched the first international clinical trial in Australia. This is a significant event for the company, which opens new perspectives and opportunities for growth on the international market.
iPharma is a company which specializes in development and production of innovational medical drugs. We have extensive experience, including participation in international project management, data management and biostatistics. These allow iPharma to feel confident on the international market and compete with leading companies in the sector.
The launch of the first clinical trial in Australia is an important step for iPharma. It will allow us to broaden its geographical presence, attract new partners and investors, as well as consolidate its positions on the global market.
The clinical trial, launched by iPharma in Australia aims to study the effectiveness of a new medical drug. The trial is conducted in compliance with international quality and safety standards. The results will be published in scientific journals and presented at international conferences.
We are certain that the launch of the first clinical trial in Australia will be the first stage of iPharma’s development as an international company. We are ready for cooperation with new partners and are open to new ideas and projects.